North America Dry Eye Syndrome Treatment Market Size, 2028

North America Dry Eye Syndrome Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Drug, By Dosage, By Distribution Channel (Retail Pharmacy, Hospital Pharmacy and Online Pharmacy), By Sales Channel, By Product, By Country and Growth Forecast, 2022 - 2028

Published Date: September-2022 | Number of Pages: 123 | Format: PDF | Report ID: KBV-20314

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Dry Eye Syndrome Treatment Market, by Type
1.4.2 North America Dry Eye Syndrome Treatment Market, by Drug
1.4.3 North America Dry Eye Syndrome Treatment Market, by Dosage
1.4.4 North America Dry Eye Syndrome Treatment Market, by Distribution Channel
1.4.5 North America Dry Eye Syndrome Treatment Market, by Sales Channel
1.4.6 North America Dry Eye Syndrome Treatment Market, by Product
1.4.7 North America Dry Eye Syndrome Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. North America Dry Eye Syndrome Treatment Market by Type
4.1 North America Evaporative Dry Eye Syndrome Market by Country
4.2 North America Aqueous Deficient Dry Eye Syndrome Market by Country

Chapter 5. North America Dry Eye Syndrome Treatment Market by Drug
5.1 North America Restasis Market by Country
5.2 North America Xiidra Market by Country
5.3 North America Cequa Market by Country
5.4 North America Eysuvis Market by Country
5.5 North America Tyrvaya & Others Market by Country

Chapter 6. North America Dry Eye Syndrome Treatment Market by Dosage
6.1 North America Eye drops Market by Country
6.2 North America Gels Market by Country
6.3 North America Capsules & Tablets Market by Country
6.4 North America Eye Solutions Market by Country
6.5 North America Ointments Market by Country

Chapter 7. North America Dry Eye Syndrome Treatment Market by Distribution Channel
7.1 North America Retail Pharmacy Market by Country
7.2 North America Hospital Pharmacy Market by Country
7.3 North America Online Pharmacy Market by Country

Chapter 8. North America Dry Eye Syndrome Treatment Market by Sales Channel
8.1 North America OTC Market by Country
8.2 North America Prescription Market by Country

Chapter 9. North America Dry Eye Syndrome Treatment Market by Product
9.1 North America Cyclosporine Market by Country
9.2 North America Topical Corticosteroids Market by Country
9.3 North America Artificial Tears Market by Country
9.4 North America Punctal Plugs Market by Country
9.5 North America Oral Omega Supplements Market by Country
9.6 North America Others Market by Country

Chapter 10. North America Dry Eye Syndrome Treatment Market by Country
10.1 US Dry Eye Syndrome Treatment Market
10.1.1 US Dry Eye Syndrome Treatment Market by Type
10.1.2 US Dry Eye Syndrome Treatment Market by Drug
10.1.3 US Dry Eye Syndrome Treatment Market by Dosage
10.1.4 US Dry Eye Syndrome Treatment Market by Distribution Channel
10.1.5 US Dry Eye Syndrome Treatment Market by Sales Channel
10.1.6 US Dry Eye Syndrome Treatment Market by Product
10.2 Canada Dry Eye Syndrome Treatment Market
10.2.1 Canada Dry Eye Syndrome Treatment Market by Type
10.2.2 Canada Dry Eye Syndrome Treatment Market by Drug
10.2.3 Canada Dry Eye Syndrome Treatment Market by Dosage
10.2.4 Canada Dry Eye Syndrome Treatment Market by Distribution Channel
10.2.5 Canada Dry Eye Syndrome Treatment Market by Sales Channel
10.2.6 Canada Dry Eye Syndrome Treatment Market by Product
10.3 Mexico Dry Eye Syndrome Treatment Market
10.3.1 Mexico Dry Eye Syndrome Treatment Market by Type
10.3.2 Mexico Dry Eye Syndrome Treatment Market by Drug
10.3.3 Mexico Dry Eye Syndrome Treatment Market by Dosage
10.3.4 Mexico Dry Eye Syndrome Treatment Market by Distribution Channel
10.3.5 Mexico Dry Eye Syndrome Treatment Market by Sales Channel
10.3.6 Mexico Dry Eye Syndrome Treatment Market by Product
10.4 Rest of North America Dry Eye Syndrome Treatment Market
10.4.1 Rest of North America Dry Eye Syndrome Treatment Market by Type
10.4.2 Rest of North America Dry Eye Syndrome Treatment Market by Drug
10.4.3 Rest of North America Dry Eye Syndrome Treatment Market by Dosage
10.4.4 Rest of North America Dry Eye Syndrome Treatment Market by Distribution Channel
10.4.5 Rest of North America Dry Eye Syndrome Treatment Market by Sales Channel
10.4.6 Rest of North America Dry Eye Syndrome Treatment Market by Product

Chapter 11. Company Profiles
11.1 Johnson & Johnson (Johnson & Johnson Services, Inc.)
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental &Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Product Launches and Product Expansions:
11.1.5.2 Approvals and Trials:
11.1.6 SWOT Analysis
11.2 AbbVie, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Product Launches and Product Expansions:
11.3 Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Partnerships, Collaborations, and Agreements:
11.3.5.2 Product Launches and Product Expansions:
11.4 Novartis AG
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 Recent strategies and developments:
11.4.5.1 Acquisition and Mergers:
11.5 Sun Pharmaceuticals Industries Ltd
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Regional Analysis
11.5.4 Research & Development Expenses
11.5.5 Recent strategies and developments:
11.5.5.1 Product Launches and Product Expansions:
11.5.5.2 Approvals and Trials:
11.6 AFT Pharmaceuticals
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Product Launches and Product Expansions:
11.7 Santen Pharmaceutical Co., Ltd.
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Regional Analysis
11.7.4 Research & Development Expenses
11.7.5 Recent strategies and developments:
11.7.5.1 Acquisition and Mergers:
11.7.5.2 Approvals and Trials:
11.8 Oyster Point Pharma, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Research & Development Expenses
11.8.4 Recent strategies and developments:
11.8.4.1 Partnerships, Collaborations, and Agreements:
11.8.4.2 Approvals and Trials:
11.9 OASIS Medical, Inc.
11.9.1 Company Overview
11.9.2 Recent strategies and developments:
11.9.2.1 Product Launches and Product Expansions:
11.10. Otsuka Pharmaceutical Co., Ltd.
11.10.1 Company Overview

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities